Gene therapy delivery technologies are experiencing emerging trends, with a focus on areas such as biologics formulation, fill-finish, and delivery, as well as virus and virus-like particle delivery to the brain. The market for gene delivery technologies is expected to grow, with some reports suggesting it will exceed $22.79 billion by 2034. Various companies and countries, including china, are also playing a role in the development of gene therapy solutions, with some expected to maintain an edge in early-stage drugmaking.